{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:07:43Z","timestamp":1790683663288,"version":"4.1.0"},"reference-count":297,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Associazione Giacomo Onlus"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.semcancer.2019.08.006","type":"journal-article","created":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T09:46:36Z","timestamp":1565516796000},"page":"72-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Role of ATP-binding cassette transporters in cancer initiation and progression"],"prefix":"10.1016","volume":"60","author":[{"given":"Stefania","family":"Nobili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lapucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Landini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Coronnello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Mini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","article-title":"The multistep nature of cancer","volume":"9","author":"Vogelstein","year":"1993","journal-title":"Trends Genet."},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat. Med."},{"issue":"March (5)","key":"10.1016\/j.semcancer.2019.08.006_bib0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4161\/cbt.4.6.1818","article-title":"Molecular theory of cancer","volume":"4","author":"Blagosklonny","year":"2005","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028373","article-title":"The role of aneuploidy in cancer evolution","volume":"7","author":"Sansregret","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw036","article-title":"The conundrum of genetic \u201cdrivers\u201d in benign conditions","volume":"108","author":"Kato","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"17","key":"10.1016\/j.semcancer.2019.08.006_bib0040","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl. 1","key":"10.1016\/j.semcancer.2019.08.006_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2006.07231.x","article-title":"Molecular mechanisms of cancer cell invasion and plasticity","volume":"154","author":"Wolf","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"64","key":"10.1016\/j.semcancer.2019.08.006_bib0050","doi-asserted-by":"crossref","first-page":"107685","DOI":"10.18632\/oncotarget.22591","article-title":"Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors","volume":"8","author":"Guti\u00e9rrez","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.pathmechdis.3.121806.151523","article-title":"Metastatic cancer cell","volume":"3","author":"Bacac","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0070","series-title":"London: Tumor Microenvironment Metastasis","author":"Wang","year":"2018"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Maehata","year":"2013","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/nbm.1644","article-title":"Imaging pH and metastasis","volume":"24","author":"Hashim","year":"2011","journal-title":"NMR Biomed."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF00121214","article-title":"Acidic pH enhances the invasive behavior of human melanoma cells","volume":"14","author":"Mart\u00ednez-Zaguil\u00e1n","year":"1996","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6159","key":"10.1016\/j.semcancer.2019.08.006_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/science.1234850","article-title":"Epithelial plasticity: a common theme in embryonic and cancer cells","volume":"342","author":"Nieto","year":"2013","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0105","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer stem cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib0115","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1002\/jcp.27489","article-title":"MicroRNAs and signaling networks involved in epithelial-mesenchymal transition","volume":"234","author":"Musavi Shenas","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081924","article-title":"Long noncoding RNA and epithelial mesenchymal transition in cancer","volume":"20","author":"Gugnoni","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/gcc.22691","article-title":"Molecular mechanisms of long noncoding RNAs-mediated cancer metastasis","volume":"58","author":"Li","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10555-017-9712-y","article-title":"MicroRNAs and metastasis: small RNAs play big roles","volume":"37","author":"Kim","year":"2018","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist. Updat."},{"issue":"11","key":"10.1016\/j.semcancer.2019.08.006_bib0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112362","article-title":"ABC transporters in cancer stem cells: beyond chemoresistance","volume":"18","author":"Begicevic","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.semcancer.2019.08.006_bib0150","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1016\/S0021-9258(19)42031-0","article-title":"Different mechanisms of energy coupling for the shock-sensitive and shock-resistant amino acid permeases of Escherichia coli","volume":"249","author":"Berger","year":"1974","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.jbchem.a130567","article-title":"Transport of sugars and amino acids in bacteria. X. Sources of energy and energy coupling reactions of the active transport systems for isoleucine and proline in E. coli","volume":"76","author":"Kobayashi","year":"1974","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0005-2736(74)90148-5","article-title":"Increased drug permeability in Chinese hamster ovary cells in the presence of cyanide","volume":"373","author":"See","year":"1974","journal-title":"Biochim. Biophys. Acta"},{"issue":"6282","key":"10.1016\/j.semcancer.2019.08.006_bib0165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/346362a0","article-title":"Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport","volume":"346","author":"Hyde","year":"1990","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.semcancer.2019.08.006_bib0170","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","article-title":"Multidrug efflux pumps: structure, function and regulation","volume":"16","author":"Du","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0175","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2174\/0929867323666160405112820","article-title":"Human tuberculosis II. M. Tuberculosis mechanisms of genetic and phenotypic resistance to anti-tuberculosis drugs","volume":"23","author":"Sgaragli","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fphar.2016.00535","article-title":"The role of eukaryotic and prokaryotic ABC transporter family in failure of chemotherapy","volume":"7","author":"El-Awady","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0185","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"issue":"5969","key":"10.1016\/j.semcancer.2019.08.006_bib0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/309626a0","article-title":"Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells","volume":"309","author":"Roninson","year":"1984","journal-title":"Nature"},{"issue":"6031","key":"10.1016\/j.semcancer.2019.08.006_bib0195","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/316817a0","article-title":"Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines","volume":"316","author":"Riordan","year":"1985","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0092-8674(86)90594-5","article-title":"Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins","volume":"47","author":"Gros","year":"1986","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0205","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.febslet.2005.12.060","article-title":"The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research","volume":"580","author":"Gottesman","year":"2006","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0210","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.febslet.2005.11.079","article-title":"ABC transporter architecture and regulatory roles of accessory domains","volume":"580","author":"Biemans-Oldehinkel","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0215","series-title":"ATP Binding Cassette Transporters (ABC)","author":"HUGO Gene Nomenclature Committe \u2013 Gene group","year":"2019"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0220","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1085\/jgp.201411164","article-title":"Structural diversity of ABC transporters","volume":"143","author":"ter Beek","year":"2014","journal-title":"J. Gen. Physiol."},{"issue":"February (1)","key":"10.1016\/j.semcancer.2019.08.006_bib0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BST20180147","article-title":"Learning the ABCs one at a time: structure and mechanism of ABC transporters","volume":"47","author":"Ford","year":"2019","journal-title":"Biochem. Soc. Trans."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0230","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nsmb.3216","article-title":"Mechanistic diversity in ATP-binding cassette (ABC) transporters","volume":"23","author":"Locher","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2004.01.044","article-title":"Sequence analysis of twin ATP binding cassette proteins involved in translational control, antibiotic resistance, and ribonuclease L inhibition","volume":"315","author":"Kerr","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2019.05.010","article-title":"The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma","volume":"457","author":"Fung","year":"2019","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.semcancer.2019.08.006_bib0245","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.semcancer.2019.08.006_bib0250","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1056\/NEJM198705283162207","article-title":"Multiple-drug resistance in human cancer","volume":"316","author":"Pastan","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"Pt B","key":"10.1016\/j.semcancer.2019.08.006_bib0255","first-page":"298","article-title":"Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders","volume":"1628","author":"Qosa","year":"2015","journal-title":"BrainRes"},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0260","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.arcmed.2014.11.018","article-title":"Role of the blood-brain barrier in the nutrition of the central nervous system","volume":"45","author":"Campos-Bedolla","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0265","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0270","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/37.2.2463300","article-title":"Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein","volume":"37","author":"Thiebaut","year":"1989","journal-title":"J. Histochem. Cytochem."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0275","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt.64","article-title":"Regulation of ABC transporters at the blood-brain barrier","volume":"97","author":"Miller","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/pr.58.2.3","article-title":"Multidrug resistance-associated proteins: expression and function in the central nervous system","volume":"58","author":"Dallas","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"September (5)","key":"10.1016\/j.semcancer.2019.08.006_bib0285","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1586\/14737159.5.5.755","article-title":"Molecular diagnosis of ATP-binding cassette transporter-related diseases","volume":"5","author":"Schuierer","year":"2005","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0290","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1012823120935","article-title":"Complete characterization of the human ABC gene family","volume":"33","author":"Dean","year":"2001","journal-title":"J. Bioenerg. Biomembr."},{"issue":"23","key":"10.1016\/j.semcancer.2019.08.006_bib0295","doi-asserted-by":"crossref","first-page":"24218","DOI":"10.1074\/jbc.M313599200","article-title":"The stem cell marker Bcrp\/ABCG2 enhances hypoxic cell survival through interactions with heme","volume":"279","author":"Krishnamurthy","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10534-005-3709-7","article-title":"The ABC transporter Abcg2\/Bcrp: role in hypoxia mediated survival","volume":"18","author":"Krishnamurthy","year":"2005","journal-title":"Biometals"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0305","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1073\/pnas.0406266102","article-title":"Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"33","key":"10.1016\/j.semcancer.2019.08.006_bib0310","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1021\/bi700015m","article-title":"Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane","volume":"46","author":"Paterson","year":"2007","journal-title":"Biochemistry"},{"issue":"7111","key":"10.1016\/j.semcancer.2019.08.006_bib0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nature05125","article-title":"Identification of a mammalian mitochondrial porphyrin transporter","volume":"443","author":"Krishnamurthy","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0320","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1128\/MCB.00865-13","article-title":"Abcb10 role in heme biosynthesis in vivo: Abcb10 knockout in mice causes anemia with protoporphyrin IX and iron accumulation","volume":"34","author":"Yamamoto","year":"2014","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0325","doi-asserted-by":"crossref","first-page":"G25","DOI":"10.1152\/ajpgi.00175.2006","article-title":"Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes","volume":"293","author":"Fouassier","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0330","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/03602532.2015.1007012","article-title":"MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks","volume":"47","author":"Li","year":"2015","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0335","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbagen.2018.09.019","article-title":"ABC transporters as cancer drivers: potential functions in cancer development","volume":"1863","author":"Adamska","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","article-title":"ABC transporters: from microorganisms to man","volume":"8","author":"Higgins","year":"1992","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0345","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejmech.2017.07.062","article-title":"Overcoming ABC transporter-mediated multidrug resistance: the dual role of tyrosine kinase inhibitors as multitargeting agents","volume":"142","author":"Beretta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0350","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1042\/BST20160040","article-title":"How to move an amphipathic molecule across a lipid bilayer: different mechanisms for different ABC transporters?","volume":"44","author":"Theodoulou","year":"2016","journal-title":"Biochem. Soc. Trans."},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib0355","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/S0021-9258(19)39690-5","article-title":"Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells","volume":"265","author":"Raviv","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0360","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0968-0004(92)90419-A","article-title":"Is the multidrug transporter a flippase?","volume":"17","author":"Higgins","year":"1992","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0365","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biopha.2018.02.038","article-title":"Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR","volume":"100","author":"Mohammad","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0370","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JCO.1985.3.3.311","article-title":"Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance","volume":"3","author":"Bell","year":"1985","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2019.08.006_bib0375","first-page":"3352","article-title":"Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin","volume":"5","author":"Abolhoda","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"May (5)","key":"10.1016\/j.semcancer.2019.08.006_bib0380","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib0385","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/138945006777709593","article-title":"Pharmacological strategies for overcoming multidrug resistance","volume":"7","author":"Nobili","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0390","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0395","series-title":"Multi-Drug Resistance: Biological and Pharmaceutical Advances in the Antitumour Treatment","first-page":"101","article-title":"Overcoming multidrug resistance: alternative approaches to P-glycoprotein modulators","author":"Nobili","year":"2008"},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0400","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.20239","article-title":"Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression","volume":"32","author":"Nobili","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0410","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lfs.2018.10.048","article-title":"Structural and functional aspects of P-glycoprotein and its inhibitors","volume":"214","author":"Mollazadeh","year":"2018","journal-title":"Life Sci."},{"issue":"23","key":"10.1016\/j.semcancer.2019.08.006_bib0415","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm030183a","article-title":"Multidrug resistance reversal agents","volume":"46","author":"Robert","year":"2003","journal-title":"J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2019.08.006_bib0420","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.drup.2012.03.001","article-title":"Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1","volume":"15","author":"Gillet","year":"2012","journal-title":"Drug Resist. Updat."},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2019.08.006_bib0425","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10555-012-9402-8","article-title":"Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?","volume":"32","author":"Yu","year":"2013","journal-title":"Cancer Metastasis Rev."},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib0430","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0435","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fonc.2015.00105","article-title":"Editorial: multidrug resistance in cancer: pharmacological strategies from basic research to clinical issues","volume":"5","author":"Riganti","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0440","series-title":"Multidrug Resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues","author":"E-book","year":"2015"},{"issue":"2940","key":"10.1016\/j.semcancer.2019.08.006_bib0445","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.113.2940.510","article-title":"Recovery from radiation injury","volume":"113","author":"Jacobson","year":"1951","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0450","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/cddiscovery.2017.2","article-title":"Haematopoietic stem cells: past, present and future","volume":"3","author":"Ng","year":"2017","journal-title":"Cell Death Discov."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0455","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.200011","article-title":"ABC transporters as phenotypic markers and functional regulators of stem cells","volume":"20","author":"Bunting","year":"2002","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0465","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(91)90141-K","article-title":"Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells","volume":"66","author":"Chaudhary","year":"1991","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.semcancer.2019.08.006_bib0470","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0475","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V99.2.507","article-title":"The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors","volume":"99","author":"Scharenberg","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0480","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/sj.leu.2404859","article-title":"ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia","volume":"21","author":"Raaijmakers","year":"2007","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0485","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.leu.2402853","article-title":"Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells","volume":"17","author":"Calado","year":"2003","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0490","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.leu.2404131","article-title":"Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38- cells","volume":"20","author":"de Grouw","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0495","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2210-10-12","article-title":"Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells","volume":"10","author":"Tang","year":"2010","journal-title":"BMC Pharmacol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0500","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/ijc.24207","article-title":"Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs","volume":"124","author":"Oevermann","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0505","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2003-12-4330","article-title":"The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage","volume":"104","author":"Jedlitschky","year":"2004","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.semcancer.2019.08.006_bib0510","first-page":"196","article-title":"The role of tumor stem-cells in regrowth of the tumor following drastic applications","volume":"15","author":"Makino","year":"1959","journal-title":"Acta Unio Int. Contra Cancrum"},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib0515","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0520","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"39","key":"10.1016\/j.semcancer.2019.08.006_bib0525","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","article-title":"A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells","volume":"101","author":"Hirschmann-Jax","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0530","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","article-title":"Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells","volume":"67","author":"Ho","year":"2007","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0535","first-page":"4900","article-title":"Identification of side population cells in human lung adenocarcinoma A549 cell line and elucidation of the underlying roles in lung cancer","volume":"15","author":"Xie","year":"2018","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0540","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.3892\/ol.2017.6606","article-title":"Characteristics of primary side population cervical cancer cells","volume":"14","author":"Wei","year":"2017","journal-title":"Oncol. Lett."},{"issue":"16","key":"10.1016\/j.semcancer.2019.08.006_bib0545","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.18632\/oncotarget.2053","article-title":"The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics","volume":"5","author":"Boesch","year":"2014","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.semcancer.2019.08.006_bib0550","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1159\/000368842","article-title":"ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer","volume":"37","author":"Xie","year":"2014","journal-title":"Oncol. Res. Treat."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0555","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/lary.21032","article-title":"Head and neck cancer stem cells: the side population","volume":"121","author":"Tabor","year":"2011","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0560","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/etm.2016.3303","article-title":"Increased multi-drug resistance and reduced apoptosis in osteosarcoma side population cells are crucial factors for tumor recurrence","volume":"12","author":"Wang","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0565","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.3892\/mmr.2015.3291","article-title":"Side population cells and drug resistance in breast cancer","volume":"11","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"19","key":"10.1016\/j.semcancer.2019.08.006_bib0570","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1073\/pnas.192276999","article-title":"Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo","volume":"99","author":"Zhou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0575","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V96.3.902.015k40_902_909","article-title":"Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo","volume":"96","author":"Bunting","year":"2000","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semcancer.2019.08.006_bib0580","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/carcin\/bgr127","article-title":"Pleural mesothelioma side populations have a precursor phenotype","volume":"32","author":"Frei","year":"2011","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.semcancer.2019.08.006_bib0585","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1007\/s13277-016-5209-5","article-title":"ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells","volume":"37","author":"Ma","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0590","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.actbio.2015.09.029","article-title":"Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense","volume":"28","author":"Chen","year":"2015","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib0595","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/dmd.118.080663","article-title":"Beyond competitive inhibition: regulation of ABC transporters by kinases and protein-protein interactions as potential mechanisms of drug-drug interactions","volume":"46","author":"Crawford","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0600","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2015.05.008","article-title":"Sp1 transcription factor: a long-standing target in cancer chemotherapy","volume":"152","author":"Vizca\u00edno","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0605","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10059-013-0191-x","article-title":"Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype","volume":"36","author":"Yang","year":"2013","journal-title":"Mol. Cells"},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0610","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/1541-7786.MCR-10-0510","article-title":"c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells","volume":"9","author":"Porro","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0615","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199601253340405","article-title":"Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma","volume":"334","author":"Norris","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0620","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/S0959-8049(97)00284-0","article-title":"Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma","volume":"33","author":"Norris","year":"1997","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0625","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1200\/JCO.2005.01.6196","article-title":"Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma","volume":"24","author":"Haber","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.semcancer.2019.08.006_bib0630","doi-asserted-by":"crossref","first-page":"19532","DOI":"10.1074\/jbc.M109.078584","article-title":"Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells","volume":"285","author":"Porro","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0635","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/138161210790232112","article-title":"Nitric oxide control of MYCN expression and multi drug resistance genes in tumours of neural origin","volume":"16","author":"Porro","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018372","article-title":"SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes","volume":"6","author":"Jeong","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0645","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1158\/1535-7163.MCT-10-0108","article-title":"Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype","volume":"9","author":"Singh","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0650","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1440-1681.12693","article-title":"Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1\u03b1 and HIF2\u03b1","volume":"44","author":"Sch\u00f6ning","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.semcancer.2019.08.006_bib0655","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCRESAHA.107.161729","article-title":"Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells","volume":"102","author":"Martin","year":"2008","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0660","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0665","article-title":"HIF-1\u03b1 inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1\/P-glycoprotein","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0670","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1756-9966-29-158","article-title":"Expression of MDR1, HIF-1\u03b1 and MRP1 in sacral chordoma and chordoma cell line CM-319","volume":"29","author":"Ji","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib0675","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s11064-008-9864-9","article-title":"Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide","volume":"34","author":"Chen","year":"2009","journal-title":"Neurochem. Res."},{"issue":"40","key":"10.1016\/j.semcancer.2019.08.006_bib0680","doi-asserted-by":"crossref","first-page":"39068","DOI":"10.1074\/jbc.M306362200","article-title":"Akt signaling regulates side population cell phenotype via Bcrp1 translocation","volume":"278","author":"Mogi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0685","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2012.07.005","article-title":"Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy","volume":"78","author":"Fischer","year":"2012","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0690","first-page":"1678","article-title":"The PI3K\/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0695","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0700","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/carcin\/bgn223","article-title":"Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling","volume":"29","author":"Hu","year":"2008","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0705","article-title":"PTEN regulates BCRP\/ABCG2 and the side population through the PI3K\/Akt pathway in chronic myeloid leukemia","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0710","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2013.04.006","article-title":"Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K\/Akt pathway in adult acute leukemia","volume":"336","author":"Huang","year":"2013","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.semcancer.2019.08.006_bib0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050690","article-title":"Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling","volume":"7","author":"Hepburn","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0720","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-4598-9-39","article-title":"Analysis of an alternative human CD133 promoter reveals the implication of Ras\/ERK pathway in tumor stem-like hallmarks","volume":"9","author":"Sasai","year":"2010","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0725","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2016.03.041","article-title":"PKC\u03b5 inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K\/Akt, MAPK\/ERK signaling in renal cell carcinoma cell line 769P","volume":"376","author":"Huang","year":"2016","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0730","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/cdd.2015.56","article-title":"HEDGEHOG\/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth","volume":"22","author":"Pandolfi","year":"2015","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0735","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12029-010-9144-1","article-title":"ABC transporters as molecular effectors of pancreatic oncogenic pathways: the Hedgehog-GLI model","volume":"41","author":"Santisteban","year":"2010","journal-title":"J. Gastrointest. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0740","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1758834010366430","article-title":"Targeting the Hedgehog pathway in cancer","volume":"2","author":"Gupta","year":"2010","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0745","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jgg.2017.04.008","article-title":"The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer","volume":"44","author":"Yu","year":"2017","journal-title":"J. Genet. Genomics"},{"issue":"16","key":"10.1016\/j.semcancer.2019.08.006_bib0750","doi-asserted-by":"crossref","first-page":"27412","DOI":"10.18632\/oncotarget.16174","article-title":"GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib0755","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/carcin\/bgg073","article-title":"The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min\/+) mice","volume":"24","author":"Mochida","year":"2003","journal-title":"Carcinogenesis"},{"issue":"16","key":"10.1016\/j.semcancer.2019.08.006_bib0760","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnci\/djr256","article-title":"ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux","volume":"103","author":"Henderson","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"7176","key":"10.1016\/j.semcancer.2019.08.006_bib0765","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","article-title":"Identification of cells initiating human melanomas","volume":"451","author":"Schatton","year":"2008","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.semcancer.2019.08.006_bib0770","first-page":"5154","article-title":"P-glycoprotein expression during tumor progression in the rat liver","volume":"52","author":"Bradley","year":"1992","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0775","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jcp.52.6.450","article-title":"Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP\/MVP occurs early in colorectal carcinogenesis","volume":"52","author":"Meijer","year":"1999","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.semcancer.2019.08.006_bib0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072119","article-title":"Low ABCB1 gene expression is an early event in colorectal carcinogenesis","volume":"8","author":"Andersen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0785","first-page":"337","article-title":"Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis","volume":"29","author":"Shibata","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0790","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/1471-2164-14-898","article-title":"Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer","volume":"14","author":"Henrique","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0795","doi-asserted-by":"crossref","DOI":"10.1038\/srep06899","article-title":"ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth","volume":"4","author":"Kiehl","year":"2014","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0800","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/labinvest.2012.100","article-title":"MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells","volume":"92","author":"Rocco","year":"2012","journal-title":"Lab. Invest."},{"issue":"March (3)","key":"10.1016\/j.semcancer.2019.08.006_bib0805","article-title":"High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence","volume":"10","author":"Andersen","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0810","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mc.22508","article-title":"A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development","volume":"56","author":"To","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib0815","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/cas.13097","article-title":"Wnt-\u03b2-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer","volume":"107","author":"Unno","year":"2016","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0820","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3892\/or.2016.4599","article-title":"Gene expression of membrane transporters: importance for prognosis and progression of ovarian carcinoma","volume":"35","author":"Elsnerova","year":"2016","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.semcancer.2019.08.006_bib0825","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.7150\/jca.19364","article-title":"Downregulation of ABC transporters in non-neoplastic tissues confers better prognosis for pancreatic and colorectal cancer patients","volume":"8","author":"Dvorak","year":"2017","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0830","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/path.2383","article-title":"Expression profile of early lung adenocarcinoma: identification of MRP3 as a molecular marker for early progression","volume":"216","author":"Hanada","year":"2008","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0835","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/carcin\/bgm096","article-title":"Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo","volume":"28","author":"Suryo Rahmanto","year":"2007","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0840","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbrc.2008.02.022","article-title":"MDR1 expression identifies human melanoma stem cells","volume":"368","author":"Keshet","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2019.08.006_bib0845","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079222","article-title":"Kinetics of MDR transport in tumor-initiating cells","volume":"8","author":"Koshkin","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib0850","first-page":"1231","article-title":"MRP and MDR1 gene expression in primary breast carcinomas","volume":"2","author":"Filipits","year":"1996","journal-title":"Clin. Cancer Res."},{"issue":"1A","key":"10.1016\/j.semcancer.2019.08.006_bib0855","first-page":"119","article-title":"P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients","volume":"21","author":"Z\u00f6chbauer-M\u00fcller","year":"2001","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0860","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1998.13","article-title":"Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression","volume":"77","author":"Beck","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0865","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/bjc.1997.414","article-title":"The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer","volume":"76","author":"Nooter","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0870","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/bcr293","article-title":"Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy","volume":"3","author":"Schneider","year":"2001","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0875","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10549-012-2398-5","article-title":"High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival","volume":"137","author":"Yamada","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0880","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1615\/JEnvironPatholToxicolOncol.2013006767","article-title":"The prognostic value of breast cancer resistance protein (BCRB\/ABCG2) expression in breast carcinomas","volume":"31","author":"Omran","year":"2012","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0885","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1746-1596-6-90","article-title":"ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma","volume":"6","author":"Xiang","year":"2011","journal-title":"Diagn. Pathol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0890","first-page":"2720","article-title":"Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis","volume":"51","author":"Weinstein","year":"1991","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0895","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bjc.1993.411","article-title":"MDR1 gene expression in primary colorectal carcinomas","volume":"68","author":"Pirker","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0900","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/bjc.1997.35","article-title":"Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas","volume":"75","author":"Fillpits","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib0905","first-page":"845","article-title":"Expression of ABCG2 and its significance in colorectal cancer","volume":"11","author":"Liu","year":"2010","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib0910","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02483030","article-title":"Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein","volume":"29","author":"Alexander","year":"1999","journal-title":"Surg. Today"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0915","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1756-9966-28-144","article-title":"The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer","volume":"28","author":"Hu","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib0920","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1478-3231.2008.01889.x","article-title":"Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin","volume":"28","author":"Vander Borght","year":"2008","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0925","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep.24682","article-title":"R\u00e9seau Centre de Ressources Biologiques Foie (French Liver Biobanks Network), France. Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs","volume":"55","author":"Borel","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0930","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2011.02772.x","article-title":"Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients","volume":"62","author":"Lee","year":"2012","journal-title":"Pathol. Int."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib0935","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.20831","article-title":"Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma","volume":"115","author":"K\u00f6nig","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0940","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.annonc.a010484","article-title":"Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer","volume":"7","author":"Nooter","year":"1996","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib0945","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ijc.2910640507","article-title":"Preferential expression of the multidrug-resistance-associated protein (MRP) in adenocarcinoma of the lung","volume":"64","author":"Sugawara","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0950","doi-asserted-by":"crossref","DOI":"10.1038\/srep03120","article-title":"ABCC3 as a marker for multidrug resistance in non-small cell lung cancer","volume":"3","author":"Zhao","year":"2013","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0955","first-page":"1393","article-title":"The expression of drug resistance gene products during the progression of human prostate cancer","volume":"4","author":"Sullivan","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib0960","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00005392-200101000-00032","article-title":"Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer","volume":"165","author":"Van Brussel","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib0965","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12885-015-1689-8","article-title":"Frequent down-regulation of ABC transporter genes in prostate cancer","volume":"15","author":"Demidenko","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086824","article-title":"TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers","volume":"9","author":"H\u00e4ggl\u00f6f","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0975","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-0215(19961220)69:6<488::AID-IJC13>3.0.CO;2-Y","article-title":"Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas","volume":"69","author":"Kubo","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.08.006_bib0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.01.036","article-title":"Exome sequencing of ABCB5 identifies recurrent melanoma mutations that result in increased proliferative and invasive capacities","author":"Sana","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0985","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.20589","article-title":"ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas","volume":"114","author":"Oda","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"50","key":"10.1016\/j.semcancer.2019.08.006_bib0990","doi-asserted-by":"crossref","first-page":"83502","DOI":"10.18632\/oncotarget.13148","article-title":"Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib0995","first-page":"1459","article-title":"May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian\/Scandinavian Sarcoma Group 1 treatment protocol","volume":"29","author":"Pasello","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib1000","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/0959-8049(95)00335-5","article-title":"Analysis of P-glycoprotein expression in osteosarcoma","volume":"31A","author":"Serra","year":"1995","journal-title":"Eur. J. Cancer"},{"issue":"22","key":"10.1016\/j.semcancer.2019.08.006_bib1005","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/89.22.1706","article-title":"P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy","volume":"89","author":"Chan","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"January (1)","key":"10.1016\/j.semcancer.2019.08.006_bib1010","article-title":"NF-kappaB is involved in the regulation of EMT genes in breast cancer cells","volume":"12","author":"Pires","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"3\u20134","key":"10.1016\/j.semcancer.2019.08.006_bib1020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10555-012-9368-6","article-title":"MicroRNA control of epithelial-mesenchymal transition and metastasis","volume":"31","author":"Zhang","year":"2012","journal-title":"Cancer Metastasis Rev."},{"issue":"5\u20136","key":"10.1016\/j.semcancer.2019.08.006_bib1025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semcancer.2012.04.003","article-title":"Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT)","volume":"22","author":"Warzecha","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib1030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ccr.2009.03.017","article-title":"Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition","volume":"15","author":"Evdokimova","year":"2009","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib1035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ncb1875","article-title":"p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. 1","volume":"11","author":"Wang","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib1040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.semcancer.2019.08.006_bib1045","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4161\/cc.10.17.17188","article-title":"Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer","volume":"10","author":"Jordan","year":"2011","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib1050","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1158\/0008-5472.CAN-08-3343","article-title":"Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells","volume":"69","author":"Santisteban","year":"2009","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib1055","first-page":"2575","article-title":"Overexpression of snail accelerates adriamycin induction of multidrug resistance in breast cancer cells","volume":"12","author":"Li","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1060","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.61","article-title":"Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters","volume":"2","author":"Saxena","year":"2011","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3892\/ijo.2016.3342","article-title":"Twist mediates an aggressive phenotype in human colorectal cancer cells","volume":"48","author":"Deng","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib1070","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.bbamcr.2013.07.021","article-title":"Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer","volume":"1833","author":"Zhang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib1075","first-page":"2004","article-title":"MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells","volume":"20","author":"Li","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib1080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bcp.2008.06.007","article-title":"Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1\/P-glycoprotein expression in human cancer cells","volume":"76","author":"Zhu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1085","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.12659\/MSM.898415","article-title":"MiR-30a decreases multidrug resistance (MDR) of gastric cancer cells","volume":"22","author":"Li","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1090","first-page":"149","article-title":"The ABCs of human alternative splicing: a review of ATP-binding cassette transporter splicing","volume":"12","author":"Srinivasan","year":"2009","journal-title":"Curr. Opin. Drug Discov. Dev."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib1095","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1208\/s12248-017-0150-0","article-title":"Alternative splicing: expanding diversity in major ABC and SLC drug transporters","volume":"19","author":"Park","year":"2017","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2144\/98252st01","article-title":"Use of long RT-PCR to characterize splice variant mRNAs","volume":"25","author":"Hu","year":"1998","journal-title":"Biotechniques"},{"issue":"14","key":"10.1016\/j.semcancer.2019.08.006_bib1105","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-03-0439","article-title":"Alternative splicing of the multidrug resistance protein 1\/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20","volume":"10","author":"He","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00280-017-3340-7","article-title":"ABCC4 functional SNP in the 3\u2019 splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia","volume":"80","author":"Mesrian Tanha","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1115","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5874127","article-title":"CCL21 facilitates chemoresistance and Cancer stem cell-like properties of colorectal Cancer cells through AKT\/GSK-3\u03b2\/snail signals","volume":"2016","author":"Lu","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1120","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/0008-5472.CAN-07-2545","article-title":"ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition","volume":"68","author":"Yin","year":"2008","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.semcancer.2019.08.006_bib1125","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/bjc.2014.528","article-title":"SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma","volume":"111","author":"Lee","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bcp.2013.11.003","article-title":"P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells","volume":"87","author":"Zhang","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1135","first-page":"99","article-title":"Identification of the interaction between P-glycoprotein and Anxa2 in multidrug-resistant human breast cancer cells","volume":"9","author":"Zhang","year":"2012","journal-title":"Cancer Biol. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib1140","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4161\/cc.24636","article-title":"PPAR\u03b4 promotes oncogenic redirection of TGF-\u03b21 signaling through the activation of the ABCA1-Cav1 pathway","volume":"12","author":"Her","year":"2013","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1145","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.celrep.2012.08.011","article-title":"Anticancer activity of the cholesterol exporter ABCA1 gene","volume":"2","author":"Smith","year":"2012","journal-title":"Cell Rep."},{"issue":"28","key":"10.1016\/j.semcancer.2019.08.006_bib1150","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1074\/jbc.RA118.003187","article-title":"ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer","volume":"293","author":"Guo","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1155","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3727\/096504016X14734149559061","article-title":"ABCB5-ZEB1 axis promotes invasion and metastasis in breast cancer cells","volume":"25","author":"Yao","year":"2017","journal-title":"Oncol. Res."},{"issue":"2\u20133","key":"10.1016\/j.semcancer.2019.08.006_bib1160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000069852","article-title":"The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an extracellular domain encoded in part by a 4.8-kb conserved exon","volume":"98","author":"Prades","year":"2002","journal-title":"Cytogenet. Genome Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1165","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3892\/mmr.2016.5388","article-title":"Expression of ATP binding cassette E1 enhances viability and invasiveness of lung adenocarcinoma cells in vitro","volume":"14","author":"Tian","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib1170","first-page":"698","article-title":"ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma","volume":"4","author":"Xie","year":"2014","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/jm8012745","article-title":"N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors","volume":"52","author":"Martelli","year":"2009","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib1180","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1021\/jm9016174","article-title":"Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors","volume":"53","author":"Martelli","year":"2010","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1185","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bmc.2012.11.019","article-title":"New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR)","volume":"21","author":"Orlandi","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejmech.2014.09.084","article-title":"Multidrug resistance (MDR) reversers: high activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters","volume":"87","author":"Dei","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejmech.2019.03.054","article-title":"Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators","volume":"172","author":"Dei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib1200","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/17425255.2016.1179280","article-title":"Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells","volume":"12","author":"McIntosh","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2017.03.003","article-title":"The challenge of targeting cancer stem cells to halt metastasis","volume":"44","author":"Agliano","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1210","first-page":"1703","article-title":"The PI3K\/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation","volume":"27","author":"Imai","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance- associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"Tazzari","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2019.08.006_bib1220","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1158\/0008-5472.CAN-04-1612","article-title":"Phosphatidylinositol 3\u2019-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells","volume":"64","author":"Lee","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejps.2006.08.006","article-title":"LY294002, a specific inhibitor of PI3K\/Akt kinase pathway, antagonizes P-glycoprotein- mediated multidrug resistance","volume":"29","author":"Baranc\u00edk","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1230","series-title":"A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors (SF112600106)","year":"2019"},{"key":"10.1016\/j.semcancer.2019.08.006_bib1235","series-title":"SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and\/or PI-3 Kinase Pathway Genes","year":"2019"},{"key":"10.1016\/j.semcancer.2019.08.006_bib1240","series-title":"SF1126 for Patients With Relapsed or Refractory Neuroblastoma","year":"2019"},{"key":"10.1016\/j.semcancer.2019.08.006_bib1245","series-title":"Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma","year":"2019"},{"key":"10.1016\/j.semcancer.2019.08.006_bib1250","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/950658","article-title":"Salinomycin as a drug for targeting human cancer stem cells","volume":"2012","author":"Naujokat","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2010.03.008","article-title":"The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor","volume":"45","author":"Riccioni","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"issue":"20","key":"10.1016\/j.semcancer.2019.08.006_bib1260","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1073\/pnas.83.20.7785","article-title":"Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies","volume":"83","author":"Hamada","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1265","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<435::AID-IJC20>3.0.CO;2-5","article-title":"Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16","volume":"67","author":"Naito","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"19","key":"10.1016\/j.semcancer.2019.08.006_bib1270","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/jnci\/83.19.1386","article-title":"Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody","volume":"83","author":"Pearson","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib1275","first-page":"3209","article-title":"Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells","volume":"49","author":"Meyers","year":"1989","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1280","first-page":"310","article-title":"Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein","volume":"53","author":"Arceci","year":"1993","journal-title":"Cancer Res."},{"issue":"47","key":"10.1016\/j.semcancer.2019.08.006_bib1285","doi-asserted-by":"crossref","first-page":"47156","DOI":"10.1074\/jbc.M308700200","article-title":"Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter","volume":"278","author":"Frank","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib1290","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.celrep.2015.08.010","article-title":"ABCB5 identifies immunoregulatory dermal cells","volume":"12","author":"Schatton","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1295","series-title":"ABCB1\/P-Glycoprotein Expression As Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma (ISG\/OS-2)","year":"2019"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1300","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13053","article-title":"Detection of ABCB5 tumour antigen-specific CD8(+) T cells in melanoma patients and implications for immunotherapy","volume":"191","author":"Borchers","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/17425247.2011.554817","article-title":"Strategies for tumor-directed delivery of siRNA","volume":"8","author":"Chowdhury","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib1310","first-page":"1515","article-title":"Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells","volume":"63","author":"Wu","year":"2003","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.semcancer.2019.08.006_bib1315","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/sj.gt.3302269","article-title":"Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1","volume":"11","author":"Yag\u00fce","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1320","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-015-0275-x","article-title":"New trends for overcoming ABCG2\/BCRP-mediated resistance to cancer therapies","volume":"34","author":"Westover","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1325","first-page":"2473","article-title":"Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs","volume":"7","author":"Li","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib1330","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1158\/1078-0432.CCR-05-0038","article-title":"In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein","volume":"11","author":"Pichler","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib1335","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejps.2005.12.002","article-title":"siRNA--getting the message out","volume":"27","author":"Lee","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7291","key":"10.1016\/j.semcancer.2019.08.006_bib1340","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib1345","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-12-0429","article-title":"First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement","volume":"3","author":"Tabernero","year":"2013","journal-title":"Cancer Discov."},{"issue":"March 28","key":"10.1016\/j.semcancer.2019.08.006_bib1350","article-title":"Targeting siRNA in colorectal cancer therapy: nanotechnology comes into view","author":"Aghamiri","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"42","key":"10.1016\/j.semcancer.2019.08.006_bib1355","first-page":"5930","article-title":"Current understanding of interactions between nanoparticles and ABC transporters in cancer cells","volume":"25","author":"Zhang","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.semcancer.2019.08.006_bib1360","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/clpt.2008.174","article-title":"Challenges and opportunities for local and systemic delivery of siRNA and antisense oligonucleotides","volume":"84","author":"Sepp-Lorenzino","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib1365","first-page":"311","article-title":"Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance","volume":"6","author":"Quattrone","year":"1994","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1370","first-page":"419","article-title":"Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression","volume":"286","author":"Alahari","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1375","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.cgt.7700145","article-title":"A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1","volume":"7","author":"Stuart","year":"2000","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1380","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0006-2952(00)00310-5","article-title":"Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates","volume":"60","author":"Astriab-Fisher","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.semcancer.2019.08.006_bib1385","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.biopha.2004.05.015","article-title":"In vitro reversal MDR of human carcinoma cell line by an antisense oligodeoxynucleotide-doxorubicin conjugate","volume":"58","author":"Ren","year":"2004","journal-title":"Biomed. Pharmacother."},{"issue":"19","key":"10.1016\/j.semcancer.2019.08.006_bib1390","first-page":"4332","article-title":"In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides","volume":"56","author":"Cucco","year":"1996","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1395","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bcp.12987","article-title":"Therapeutic nucleic acids: current clinical status","volume":"82","author":"Sridharan","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1400","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.semcancer.2019.08.006_bib1405","first-page":"3986","article-title":"Targeting ABCB1-mediated tumor multidrug resistance by CRISPR\/Cas9-based genome editing","volume":"8","author":"Yang","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1410","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3549(15)00171-9","article-title":"Complete knockout of endogenous Mdr1 (Abcb1) in MDCK cells by CRISPR-Cas9","volume":"105","author":"Simoff","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"15","key":"10.1016\/j.semcancer.2019.08.006_bib1415","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/jnci\/82.15.1234","article-title":"\u201cTurning the tables\u201d\u2013making normal marrow resistant to chemotherapy","volume":"82","author":"Bertino","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.semcancer.2019.08.006_bib1420","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1470-2045(02)00678-2","article-title":"Myeloprotection with drug-resistance genes","volume":"3","author":"Banerjee","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1425","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/978-1-59745-561-9_34","article-title":"Chemoprotection by transfer of resistance genes","volume":"542","author":"Budak-Alpdogan","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.08.006_bib1430","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.1128\/jvi.69.12.7541-7547.1995","article-title":"Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells","volume":"69","author":"Baum","year":"1995","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1435","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V92.1.83.413k09_83_92","article-title":"Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny","volume":"92","author":"Cheng","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1440","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/10430340050016012","article-title":"Retroviral vector-mediated gene expression in human CD34+CD38- cells expanded in vitro: cis elements of FMEV are superior to those of Mo-MuLV","volume":"11","author":"Tsuji","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2019.08.006_bib1445","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.88.2.547","article-title":"Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance","volume":"88","author":"Mickisch","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.semcancer.2019.08.006_bib1450","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V79.4.1087.bloodjournal7941087","article-title":"Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice","volume":"79","author":"Mickisch","year":"1992","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2019.08.006_bib1455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1998.16.1.165","article-title":"Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation","volume":"16","author":"Hesdorffer","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib1460","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1349-7006.2007.00571.x","article-title":"Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients","volume":"98","author":"Takahashi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2019.08.006_bib1465","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-015-0260-4","article-title":"Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1)","volume":"34","author":"Brennig","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2019.08.006_bib1470","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.fpc.0000178311.02878.83","article-title":"Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability","volume":"15","author":"Wang","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib1475","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.semcancer.2019.08.006_bib1480","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1007\/s11033-012-1554-7","article-title":"MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies","volume":"39","author":"Sheng","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2019.08.006_bib1485","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00432-012-1171-9","article-title":"MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies","volume":"138","author":"Wang","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19302287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19302287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T13:05:11Z","timestamp":1715864711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19302287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":297,"alternative-id":["S1044579X19302287"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.006","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of ATP-binding cassette transporters in cancer initiation and progression","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}